Stephens Investment Management Group LLC trimmed its position in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 331,221 shares of the technology company's stock after selling 24,252 shares during the period. Stephens Investment Management Group LLC owned approximately 1.09% of HealthStream worth $10,533,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Copeland Capital Management LLC increased its position in shares of HealthStream by 17,363.4% during the fourth quarter. Copeland Capital Management LLC now owns 379,306 shares of the technology company's stock worth $12,062,000 after acquiring an additional 377,134 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its stake in shares of HealthStream by 26.9% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 76,260 shares of the technology company's stock worth $2,425,000 after acquiring an additional 16,166 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of HealthStream by 4.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 61,856 shares of the technology company's stock worth $1,967,000 after acquiring an additional 2,534 shares in the last quarter. Ellsworth Advisors LLC lifted its stake in shares of HealthStream by 7.9% in the fourth quarter. Ellsworth Advisors LLC now owns 21,617 shares of the technology company's stock worth $687,000 after acquiring an additional 1,582 shares in the last quarter. Finally, Annex Advisory Services LLC acquired a new position in shares of HealthStream in the fourth quarter worth about $1,149,000. 69.58% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently commented on the company. Canaccord Genuity Group boosted their price target on HealthStream from $28.00 to $29.00 and gave the stock a "hold" rating in a research note on Wednesday, October 23rd. Barclays boosted their price target on HealthStream from $32.00 to $34.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 23rd. Craig Hallum upgraded HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. Finally, JMP Securities reiterated a "market perform" rating on shares of HealthStream in a research note on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, HealthStream currently has a consensus rating of "Moderate Buy" and a consensus price target of $31.50.
Read Our Latest Report on HealthStream
HealthStream Trading Up 2.1 %
NASDAQ HSTM traded up $0.71 on Thursday, hitting $33.93. 153,826 shares of the stock traded hands, compared to its average volume of 119,087. The stock has a 50-day moving average of $32.22 and a 200 day moving average of $30.47. HealthStream, Inc. has a twelve month low of $23.92 and a twelve month high of $34.18. The company has a market capitalization of $1.03 billion, a P/E ratio of 52.20, a price-to-earnings-growth ratio of 4.30 and a beta of 0.39.
HealthStream Company Profile
(
Free Report)
HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.
Read More

Before you consider HealthStream, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthStream wasn't on the list.
While HealthStream currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.